Gossec, L., Sellas, A., Gruben, D. C., Valderrama, M., Gómez, S., Kinch, C., & Citera, G. (2025). Response to Tofacitinib in Patients with Psoriatic Arthritis and Probable Anxiety/Depressive Disorder: A Post Hoc Analysis of Phase 3 Trials. Rheumatology & Therapy, 12(6), 1175. https://doi.org/10.1007/s40744-025-00800-7
Chicago Style (17th ed.) CitationGossec, Laure, Agustí Sellas, David C. Gruben, Mónica Valderrama, Susana Gómez, Cassandra Kinch, and Gustavo Citera. "Response to Tofacitinib in Patients with Psoriatic Arthritis and Probable Anxiety/Depressive Disorder: A Post Hoc Analysis of Phase 3 Trials." Rheumatology & Therapy 12, no. 6 (2025): 1175. https://doi.org/10.1007/s40744-025-00800-7.
MLA (9th ed.) CitationGossec, Laure, et al. "Response to Tofacitinib in Patients with Psoriatic Arthritis and Probable Anxiety/Depressive Disorder: A Post Hoc Analysis of Phase 3 Trials." Rheumatology & Therapy, vol. 12, no. 6, 2025, p. 1175, https://doi.org/10.1007/s40744-025-00800-7.